Aνταλένα Τσατσοπούλου ΝΙΚΟΣ ΠΡΩΤΟΝΟΤΑΡΙΟΣ ΙΑΤΡΙΚΟ ΚΕΝΤΡΟ - ΝΑΞΟΣ. Arrhythmogenic Cardiomyopathy

Size: px
Start display at page:

Download "Aνταλένα Τσατσοπούλου ΝΙΚΟΣ ΠΡΩΤΟΝΟΤΑΡΙΟΣ ΙΑΤΡΙΚΟ ΚΕΝΤΡΟ - ΝΑΞΟΣ. Arrhythmogenic Cardiomyopathy"

Transcription

1 Aνταλένα Τσατσοπούλου ΝΙΚΟΣ ΠΡΩΤΟΝΟΤΑΡΙΟΣ ΙΑΤΡΙΚΟ ΚΕΝΤΡΟ - ΝΑΞΟΣ Arrhythmogenic Cardiomyopathy

2 Aνταλένα Τσατσοπούλου ΝΙΚΟΣ ΠΡΩΤΟΝΟΤΑΡΙΟΣ ΙΑΤΡΙΚΟ ΚΕΝΤΡΟ - ΝΑΞΟΣ There is no conflict of interest

3 Arrhythmogenic Cardiomyopathy Phenotype

4 Arrhythmogenic Cardiomyopathy Phenotype Recognise the Spectrum

5 Arrhythmogenic Cardiomyopathy Phenotype VT

6 Arrhythmogenic Cardiomyopathy Phenotype Re-entry VT

7 ECG Repolarization Depolarization Abnormalities V1 V2 V3 Re-entry VT

8 ECG Repolarization Depolarization Abnormalities V1 V2 V3 IMAGING RV Functional / Structural Alterations

9

10 PHENOTYPES Juvenile sudden deaths HCM Uhl s Normal coronaries

11 TFC 1994 ARVD / C

12 I ARVC - TFC Diagnostic Criteria ARRHYTHMIAS II III IV V VI REPOLARIZATION ABNORMALITIES DEPOLARIZATION ABNORMALITIES STRUCTURAL / WALL MOTION STRUCTURAL (TISSUE CHARACTER) FAMILY HISTORY / GENETICS Major or Minor Definite ARVC: 2 Major or 1 Major + 2 minor or 4 minor Borderline ARVC: 1 Major + 1 minor or 3 minor Suspected ARVC: 1 Major or 2 minor Unlike ARVC: 0 or 1 minor -

13 Dominant Recessive

14 Dominant Recessive

15 PHENOTYPE ~ CLINICAL PICTURE ECG, Str/Funct Birth Adolescence Age

16 SKIN MYOCARDIUM

17 SKIN Affected cell-cell contacts (desmosomes) MYOCARDIUM Plakoglobin McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, Norman M, Baboonian C, Jeffery S, McKenna WJ. Lancet 2000

18

19 RV + LV Family studies

20 RV + LV JACC 2001 Pinamonti B, Sinagra G, Salvi A, et al. Left ventricular involvement in right ventricular dysplasia. Am Heart J 1992;123: Norman M, Simpson M, Mogensen J, et al. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation 2005;112:636. Bauce B, Basso C, Rampazzo A, et al. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J 2005;26(16): Sen-Chowdhry S, Syrris P, Prasad SK, et al. Left-dominant arrhythmo-genic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol 2008;52:2175. Available online at Journal of Electrocardiology xx (2013) xxx xxx Quarta G, et al. ARVC and Lamin A/C gene mutations; Eur Heart J 2012 Kato K, Takahashi N, Fujii Y, et al. LMNA cardiomyopathy detected in Japanese arrhythmogenic right ventricular cardiomyopathy cohort. J Cardiol 2016;68(4): Left dominant arrhythmogenic cardiomyopathy: A morbid association of ventricular arrhythmias and unexplained infero-lateral T-wave inversion Alexandros Protonotarios, a, Alexandros Patrianakos, a Elpida Spanoudaki, b Georgios Kochiadakis, a Emmanouel Michalodimitrakis, b Panagiotis Vardas a a Department of Cardiology, University Hospital of Heraklion, Heraklion, Greece b Department of Forensic Sciences, University Hospital of Heraklion, Heraklion, Greece Ortiz-Genga MF, Cuenca S, Dal Ferro M, et al. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. J Am Coll Cardiol 2016;68 Abstract Left-dominant arrhythmogenic cardiomyopathy is a subtype of arrhythmogenic right ventricular cardiomyopathy characterized by early predominant left ventricular involvement. Α 34-year-old man presentedwithpalpitationsandahistory of frequent ventricular extrasystolesof bothlbbb andrbbb configuration. Cardiac workup revealed repolarization abnormalities at infero-lateral leads in the absence of diagnostic structural/functional alterations or obstructive coronary artery disease. Six months later he died suddenly. Histopathology was diagnostic for arrhythmogenic right ventricular cardiomyopathy affecting predominantly theleft ventricleat subepicardial/midwall myocardial layers. Thus, ventricular arrhythmias accompanied by unexplained infero-lateral T-wave inversion should warn of apossible morbid association underlying left-dominant arrhythmogenic cardiomyopathy. Begay RL, et al. Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell Cell Adhesion Structures. J Am Col Cardiol EP; 2018

21 Three main patterns of cardiac involvement are observed: 1. Predominant right ventricular disease, with minor or absent left ventricular involvement. 2. Biventricular disease, when both ventricles are affected. 3. Left dominant disease that is characterized by mild or absent right ventricular involvement. Terminology poorly defined Overlaps with dilated cardiomyopathy

22 Arrhythmogenic Dilated Cardiomyopathy (ADC) Recent registry study: Arrhythmogenic dilated cardiomyopathy (DCM) = DCM phenotype with 1 or more of the following: 1. Unexplained syncope (likely due to ventricular tachyarrhythmia). 2. Rapid non-sustained ventricular tachycardia defined as 5 consecutive ventricular beats lasting <30 seconds, with a rate 150/min on 24 hour Holter monitoring. 3. or 1000 premature ventricular contractions in, or 50 couplets, in 24 hours. 4. By these criteria, one third of DCM patients had an arrhythmogenic phenotype that was associated with an increased risk of arrhythmia during follow up. 5. A family history of ventricular arrhythmias predicted a poor prognosis and an increased risk of sudden cardiac death (SCD).

23 TFC Borderline phenotype minor disease TFC Borderline = borderline fitting to ARVC

24 Man, 43 year-old Asymptomatic

25 Man, 43 year-old Asymptomatic SD, 14 yrs Myocarditis

26 PRE-PARTICIPATION ECG?

27 Man, 43 year-old QRSf=126 ms LAS=78 ms RMS=11 μv 24-hour Holter: 324 monomorphic isolated VES TFC: 1 minor TFC: 1 minor

28 Man, 43 year-old, asymptomatic No diagnostic TFC structural / functional changes on ECHO - CMR CMR-Late Enhancement Imaging Extensive LV-LGE Scar in LV!

29 SD, previous day of admission for ICD implantation LV

30 Man, 43 year-old, asymptomatic SD 55y 60y DSP:Trp180Stop SD, 14 yrs DSP mutations mostly associated with Left- Dominant ARVC Diagnostic challenge Increased Risk for SD

31 Flow chart for ICD implantation Typical ARVC? Corrado D et al. Circulation 2015

32 Flow chart for ICD implantation Typical ARVC LV Scar Corrado D et al. Circulation 2015

33 Flow chart for ICD implantation Typical ARVC LV Scar Corrado D et al. Circulation 2015 DSP LMNA/C FLNC...

34 Man, 34 year-old

35 Man, 34 year-old Palpitations since 27-year-old No reports of syncope or pre-syncope No family history of cardiomyopathy or sudden death

36 Man, 34 year-old

37 Man, 34 year-old Low QRS voltage T-wave inversion in infero-lateral leads

38 RVOT=30 mm (<32 mm) LVEDD=59 mm (<58 mm) LVEF=60% Borderline cavity size Good function

39 LVEDD=59 mm LVEF=60% Regional hypokinesia of LV apex Mild regional wall motion abnormalities

40 Modified Apical View Mild hypokinesia of RV apex Mild regional wall motion abnormalities

41 Holter: VES >1000/24 h No VT 12-lead ECG: (Infero)lateral repolarization abnormalities ΕCHO: Mild/regional hypokinesia of LV/RV apex Exercise Test: Negative for myocardial ischemia No VT Coronary arteriography: No stenoses CMR-LE Metoprolol (50mgx2) and aspirin (100mgx1)

42 SD at rest Autopsy / Histopathology Eosin - Hematoxylin Masson Heart weight: 550 gr Fibrotic sub-epicardial / mid-wall bands in antero-lateral and postero-apical LV wall

43 K-Cr2707 Control N-Cadherin Plakoglobin Plakophilin2 Desmoplakin Connexin43 No desmosomal mutation

44 Ortiz-Genga, M.F. et al. J Am Coll Cardiol. 2016

45 FLNC Ortiz-Genga, M.F. et al. J Am Coll Cardiol. 2016

46

47

48 LV RV

49

50 DCM SD, 58 yrs Paroxysmal AF RV, LV progressive SD, 67 yrs Paroxysmal AF Bradycardia episodes No str/funct RV/LV Quarta G, et al. ARVC and Lamin A/C gene mutations; Eur Heart J 2012

51 50% loss of myocytes Control PG Immunostaining Quarta G, et al. ARVC and Lamin A/C gene mutations; Eur Heart J 2012

52 DCM SD, 58 yrs LMNA Paroxysmal AF RV, LV progressive SD, 67 yrs Paroxysmal AF Bradycardia episodes No str/funct RV/LV Quarta G, et al. ARVC and Lamin A/C gene mutations; Eur Heart J 2012

53 FLNC LMNA/C

54 Key points for Arrhythmogenic Cardiomyopathy A group of myocardial disorders with a high burden of ventricular arrhythmias AC is familial in about 60% of cases AC can affect one or both ventricles Three major sub-phenotypes: classical ARVC, left dominant ARVC, Arrhythmogenic DCM ECG abnormalities can precede overt structural manifestations. Exercise may promote disease progression and ventricular arrhythmia. Phenotype progresses during time: FU is important

55 Key points for Arrhythmogenic Cardiomyopathy Diagnostic criteria and management guidance exist for classical ARVC but further studies are required for other forms of AC

56 Key points for Arrhythmogenic Cardiomyopathy Symptomatic presentation of ventricular arrhythmias or a history of arrhythmic cardiac arrest in an otherwise normal myocardium should raise suspicion of an early AC phenotype.

57 TFC classical ARVC THE PHENOTYPES Early forms Left dominant ARVC Arrhythmogenic DCM Myocarditis Sarcoid The hidden phenotypes

58

59

60 Conditions affecting the Right Ventricle and Red Flags differentiating from ARVC Conditions affecting the RV and red flags differentiating from ARVC Cardiac displacement Pectus excavatum/ carinatum Kyphoscoliosis and/or another chest deformity Partial absence of pericardium RV pressure or volume overload Congenital heart defects - Ostium secundum - Sinus venosus - Ebstein s anomaly and/or tricuspid regurgitation Careful chest inspection for deformities and correlation of anatomy with CMR imaging To be excluded by TTE and/or CMR Absence of regional wall motion abnormalities Pulmonary Hypertension To be excluded by TTE and/or CMR. Absence of regional wall motion abnormalities Athlete s heart T-wave inversion extremely rare beyond V3 in whites. Myocardial Scarring Infectious myocarditis Absence of regional wall motion abnormalities. Symmetrical increase of wall thickness. Absence of LGE on CMR. Reversal upon deconditioning. Absence of familial disease Prodrome of an upper respiratory or GI tract infection Rapidly progressing ventricular dysfunction Sarcoidosis Inferior myocardial infarction Absence of familial disease 2 nd or 3 rd Degree atrioventricular block Extra-cardiac manifestations (pulmonary, mediastinum): chest x-ray, CT, PET, CMR-LGE. Evaluation of coronary artery anatomy A. Tsatsopoulou, E. Bossone, Common presentation of rare diseases: Arrhythmogenic right ventricular cardiomyopathy and its mimics, Int J Cardiol (2018), (In Press)

61 Not always as it seems to be

Update on use of cardiac MRI in ARVC/D. Stefan L. Zimmerman, MD Johns Hopkins University Department of Radiology

Update on use of cardiac MRI in ARVC/D. Stefan L. Zimmerman, MD Johns Hopkins University Department of Radiology Update on use of cardiac MRI in ARVC/D Stefan L. Zimmerman, MD Johns Hopkins University Department of Radiology Outline Background Diagnosis Characteristic imaging findings Genetics of ARVC Genotype phenotype

More information

Arrhythmogenic Cardiomyopathy cases. Δέσποινα Παρχαρίδου Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογική κλινική ΑΧΕΠΑ

Arrhythmogenic Cardiomyopathy cases. Δέσποινα Παρχαρίδου Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογική κλινική ΑΧΕΠΑ Arrhythmogenic Cardiomyopathy cases Δέσποινα Παρχαρίδου Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογική κλινική ΑΧΕΠΑ Definition ARVD (Arrhythmogenic Right Ventricular Dysplasia) Progressive loss of

More information

Implications of the new diagnostic criteria for ARVC

Implications of the new diagnostic criteria for ARVC EUROECHO 2010 Echocardiographic assessment of cardiomyopathies Implications of the new diagnostic criteria for ARVC Barbara Bauce, MD, PhD Department of Cardiac, Thoracic and Vascular Sciences University

More information

Prevention of Sudden Death in ARVC

Prevention of Sudden Death in ARVC ESC Munich, August 29, 2012 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Prevention of Sudden Death in ARVC Thomas Wichter, MD, FESC Professor of Medicine - Cardiology Marienhospital Osnabrück

More information

INTRODUCTION. left ventricular non-compaction is a sporadic or familial cardiomyopathy characterized by

INTRODUCTION. left ventricular non-compaction is a sporadic or familial cardiomyopathy characterized by A Rare Case of Arrhythmogenic Right Ventricular Cardiomyopathy Co-existing with Isolated Left Ventricular Non-compaction NS Yelgeç, AT Alper, Aİ Tekkeşin, C Türkkan INTRODUCTION Arrhythmogenic right ventricular

More information

BMR Medicine. Case Study YOUNG PATIENT WITH RECURRENT PRESYNCOPE: A CASE REPORT

BMR Medicine. Case Study YOUNG PATIENT WITH RECURRENT PRESYNCOPE: A CASE REPORT www.bmrjournals.com Open Access Scientific Publisher Case Study YOUNG PATIENT WITH RECURRENT PRESYNCOPE: A CASE REPORT ABSTRACT Manish Ruhela *, Vijay Pathak, Anoop Jain, Department of Cardiology, Sawai

More information

Clinical aspects of Arrhythmogenic Cardiomyopathies

Clinical aspects of Arrhythmogenic Cardiomyopathies Clinical aspects of Arrhythmogenic Cardiomyopathies INTERNATIONAL CLINICAL CARDIOVASCULAR GENETICS CONFERENCE 25 May 2018 Dr Hari Raju MBChB PhD ECES FRACP Clinical Associate Professor, Macquarie University,

More information

Unusual Serial Electrocardiographic Changes which Progressed to Arrhythmogenic Right Ventricular Cardiomyopathy

Unusual Serial Electrocardiographic Changes which Progressed to Arrhythmogenic Right Ventricular Cardiomyopathy CASE REPORT Unusual Serial Electrocardiographic Changes which Progressed to Arrhythmogenic Right Ventricular Cardiomyopathy Shu Yoshihara 1,2, Masaki Matsunaga 2, Taku Yaegashi 3, Shioto Suzuki 4, Masaaki

More information

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology Managing Hypertrophic Cardiomyopathy with Imaging Gisela C. Mueller University of Michigan Department of Radiology Disclosures Gadolinium contrast material for cardiac MRI Acronyms Afib CAD Atrial fibrillation

More information

Name of Presenter: Marwan Refaat, MD

Name of Presenter: Marwan Refaat, MD NAAMA s 24 th International Medical Convention Medicine in the Next Decade: Challenges and Opportunities Beirut, Lebanon June 26 July 2, 2010 I have no actual or potential conflict of interest in relation

More information

FANS ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy) Investigation Protocol

FANS ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy) Investigation Protocol Clinical Features FANS ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy) Investigation Protocol History: Progressive disease, characterised by the following clinical stages: o Early concealed phase

More information

Benign RVOT Ectopy and RV dysplasia

Benign RVOT Ectopy and RV dysplasia Heart Rhythm Congress Birmingham October 2009 How to distinguish between... Benign RVOT Ectopy and RV dysplasia in the child... Dr Graham Stuart 14yr old boy asymptomatic irregular pulse picked up by GP

More information

Heart Rhythm Disorders. How do you quantify risk?

Heart Rhythm Disorders. How do you quantify risk? Heart Rhythm Disorders How do you quantify risk? Heart Rhythm Disorders Scale of the Problem 1/2 population will have an episode of transient loss of consciousness (T-LOC) at some stage in their life.

More information

DELAYED ENHANCEMENT IMAGING IN CHILDREN

DELAYED ENHANCEMENT IMAGING IN CHILDREN NASCI 38 TH ANNUAL MEENG, SEATLE October 3-5, 21 1. DELAYED ENHANCEMENT IN CHILDREN Shi-Joon Yoo, MD Lars Grosse-Wortmann, MD University of Toronto Canada -1. 1. 1. Magnitude image Magnitude images -1.

More information

27-year-old professionnal rugby player: asymptomatic

27-year-old professionnal rugby player: asymptomatic 27-year-old professionnal rugby player: asymptomatic Benefits and limits of cardiac MRI in the young athlete with a suspected heart disease. Philippe PAULE Service de Cardiologie, HIA Clermont Tonnerre,

More information

DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY. David SIU MD ( 蕭頌華醫生 ) Division of Cardiology The University of Hong Kong

DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY. David SIU MD ( 蕭頌華醫生 ) Division of Cardiology The University of Hong Kong APHRS Summit 2018 in conjunction with HKCC Heart Rhythm Refresher Course DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY David SIU MD ( 蕭頌華醫生 ) Division of Cardiology The University of Hong Kong

More information

Arrhythmogenic Right Ventricular Cardiomyopathy. Europace June 28,2011

Arrhythmogenic Right Ventricular Cardiomyopathy. Europace June 28,2011 Arrhythmogenic Right Ventricular Cardiomyopathy Europace June 28,2011 Right Ventricular Cardiomyopathy Classical ARVC is defined as a cardiac disease mainly involving the right ventricle, characterized

More information

Sudden cardiac death: Primary and secondary prevention

Sudden cardiac death: Primary and secondary prevention Sudden cardiac death: Primary and secondary prevention By Kai Chi Chan Penultimate Year Medical Student St George s University of London at UNic Sheba Medical Centre Definition Sudden cardiac arrest (SCA)

More information

ARVC when TO IMPLANT THE ASYMPTOMATIC PERSON

ARVC when TO IMPLANT THE ASYMPTOMATIC PERSON EUROPACE 2011 INHERITED ELECTRICAL CARDIAC DISORDERS ARVC when TO IMPLANT THE ASYMPTOMATIC PERSON June 26 th 2011 Robert Lemery MD CONFLICTS of INTEREST None ASYMPTOMATIC ARVC 1. ECG 2. ASYMPTOMATIC PVC

More information

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Sports Cardiology Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Domenico Corrado, MD, PhD Inherited Arrhytmogenic Cardiomyopathy Unit Department of Cardiac, Thoracic and

More information

THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS

THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS 88 th ASMA ANNUAL SCIENTIFIC MEETING DENVER - CO April 30- May 4, 2017 THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS S. BISCONTE (1), J. MONIN (2), N. HUIBAN (3), G. GUIU (2), S. NGUYEN (1), O.

More information

Risk Factors for Sudden cardiac Death

Risk Factors for Sudden cardiac Death Risk Factors for Sudden cardiac Death A. Arenal Arrhythmias in competitive sports Disclosure Conflict of interest Advisory board: Medtronic, Boston Scientific Research grants: Medtronic, Boston Scientific,

More information

Left ventricular non-compaction: the New Cardiomyopathy on the Block

Left ventricular non-compaction: the New Cardiomyopathy on the Block Left ventricular non-compaction: the New Cardiomyopathy on the Block Aamir Jeewa MB BCh, FAAP, FRCPC Section Head, Cardiomyopathy & Heart Function Program The Hospital for Sick Children Assistant Professor

More information

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016 Echocardiographic Evaluation of the Cardiomyopathies Stephanie Coulter, MD, FACC, FASE April, 2016 Cardiomyopathies (CMP) primary disease intrinsic to cardiac muscle Dilated CMP Hypertrophic CMP Infiltrative

More information

Arrhythmias (II) Ventricular Arrhythmias. Disclosures

Arrhythmias (II) Ventricular Arrhythmias. Disclosures Arrhythmias (II) Ventricular Arrhythmias Amy Leigh Miller, MD, PhD Cardiovascular Electrophysiology, Brigham & Women s Hospital Disclosures None Rhythms and Mortality Implantable loop recorder post-mi

More information

Clinical phenotypes associated with Desmosome gene mutations

Clinical phenotypes associated with Desmosome gene mutations Clinical phenotypes associated with Desmosome gene mutations Serio A, Serafini E, Pilotto A, Pasotti M, Gambarin F, Grasso M, Disabella E, Diegoli M, Tagliani M, Arbustini E Centre for Inherited Cardiovascular

More information

Keywords: Arrhythmogenic right ventricular dysplasia/cardiomyopathy; Naxos disease; Cell adhesions;

Keywords: Arrhythmogenic right ventricular dysplasia/cardiomyopathy; Naxos disease; Cell adhesions; Naxos disease Nikos Protonotarios, MD and Adalena Tsatsopoulou, MD From Yannis Protonotarios Medical Center, Hora Naxos, Naxos 84300, Greece Keywords: Arrhythmogenic right ventricular dysplasia/cardiomyopathy;

More information

HYPERTROPHIC CARDIOMYOPATHY RISK STRATIFICATION WHAT IS NEW?

HYPERTROPHIC CARDIOMYOPATHY RISK STRATIFICATION WHAT IS NEW? HYPERTROPHIC CARDIOMYOPATHY RISK STRATIFICATION WHAT IS NEW? Division of Inherited Cardiac Diseases Heart Center for the Young and Athletes A Dpt of Cardiology University of Athens LANCET 2013 ESC HCM

More information

Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες

Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες Δημήτριος M. Κωνσταντίνου Ειδικός Καρδιολόγος, MD, MSc, PhD, CCDS Πανεπιστημιακός Υπότροφος Dr. Konstantinou

More information

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D.

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D. PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D. Cardiologist and Electrophysiologist No conflict of interest related to this presentation Objectives 1. PVCs are benign. What is the Evidence?

More information

Cardiomyopathy. Cardiomyopathies HOCM. Hypertrophic Obstructive Cardiomyopathy. Systolic Anterior Movement (SAM) of Mitral Valve (Venturi Effect) Cine

Cardiomyopathy. Cardiomyopathies HOCM. Hypertrophic Obstructive Cardiomyopathy. Systolic Anterior Movement (SAM) of Mitral Valve (Venturi Effect) Cine Jens Bremerich Radiology University Hospital Basel Hypertrophic Obstructive Cine VENC Cine (5m/s) Modified Bernoulli Equation: P (in mmhg) = 4 x (Vmax)2 Vmax= 4.2 m/s, P = 70mm Hg Hydrodynamica 738 HOCM

More information

Biventricular Arrhythmogenic Cardiomyopathy: A New Paradigm?

Biventricular Arrhythmogenic Cardiomyopathy: A New Paradigm? International Journal of Cardiovascular Sciences. 2018;31(6)667-671 667 CASE REPORT Biventricular Arrhythmogenic Cardiomyopathy: A New Paradigm? João Augusto, 1 João Abecasis, 2 Victor Gil 2 Service of

More information

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington EVALUATION OF THE 12 ATHLETE Karen Stout, MD Professor, Medicine and Pediatrics University of Washington NO DISCLOSURES OUTLINE Why evaluate athletes? What s the problem? What evaluation should be done?

More information

CONGENITAL CORONARY ARTERY ANOMALIES

CONGENITAL CORONARY ARTERY ANOMALIES How to prevent sudden coronary death in the young CONGENITAL CORONARY ARTERY ANOMALIES Cristina Basso, MD, FESC University of Padua, Italy ESC Congress Paris August 29, 2011 DECLARATION OF CONFLICT OF

More information

ECG Workshop. Nezar Amir

ECG Workshop. Nezar Amir ECG Workshop Nezar Amir Myocardial Ischemia ECG Infarct ECG in STEMI is dynamic & evolving Common causes of ST shift Infarct Localisation Left main artery occlusion: o diffuse ST-depression with ST elevation

More information

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Steven J. Kalbfleisch, M.D. Medical Director Electrophysiology Laboratory Ross Heart Hospital Wexner Medical Center Sudden

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review

More information

Index. cardiacep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. cardiacep.theclinics.com. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A AEDs. See Automated external defibrillators (AEDs) AF. See Atrial fibrillation (AF) Age as factor in SD in marathon runners, 45 Antiarrhythmic

More information

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death Cardiac Conditions in Sport & Exercise Dr Anita Green Cardiac Conditions in Sport Sudden Cardiac Death USA - Sudden Cardiac Death (SCD)

More information

Congestive Heart Failure or Heart Failure

Congestive Heart Failure or Heart Failure Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?

More information

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC Ventricular Tachycardia Ablation Saverio Iacopino, MD, FACC, FESC ü Ventricular arrhythmias, both symptomatic and asymptomatic, are common, but syncope and SCD are infrequent initial manifestations of

More information

Ablative Therapy for Ventricular Tachycardia

Ablative Therapy for Ventricular Tachycardia Ablative Therapy for Ventricular Tachycardia Nitish Badhwar, MD, FACC, FHRS 2 nd Annual UC Davis Heart and Vascular Center Cardiovascular Nurse / Technologist Symposium May 5, 2012 Disclosures Research

More information

Case based learning: CMR in Heart Failure

Case based learning: CMR in Heart Failure Case based learning: CMR in Heart Failure Milind Y Desai, MD FACC FAHA FESC Associate Professor of Medicine Heart and Vascular Institute, Cleveland Clinic Cleveland, OH Disclosures: none Use of Gadolinium

More information

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement Cardiomyopathy Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement Nebraska Home Office Life Underwriters Association March 20, 2018 1 Cardiomyopathy A myocardial disorder in which

More information

at least 4 8 hours per week

at least 4 8 hours per week ECG IN ATHLETS An athlete is defined as an individual who engages in regular exercise or training for sport or general fitness, typically with a premium on performance, and often engaged in individual

More information

Use of Biventricular Pacing in Arrhythmogenic Right Ventricular Cardiomyopathy with Disarticulated Right Ventricle

Use of Biventricular Pacing in Arrhythmogenic Right Ventricular Cardiomyopathy with Disarticulated Right Ventricle Use of Biventricular Pacing in Arrhythmogenic Right Ventricular Cardiomyopathy with Disarticulated Right Ventricle Clare Stodart (Cardiac Physiologist) University Hospital Southampton NHS Foundation Trust

More information

Clinical Policy: Holter Monitors Reference Number: CP.MP.113

Clinical Policy: Holter Monitors Reference Number: CP.MP.113 Clinical Policy: Reference Number: CP.MP.113 Effective Date: 05/18 Last Review Date: 04/18 Coding Implications Revision Log Description Ambulatory electrocardiogram (ECG) monitoring provides a view of

More information

La valutazione dell atleta: è una strategia salva-vita e costo-efficace?

La valutazione dell atleta: è una strategia salva-vita e costo-efficace? La valutazione dell atleta: è una strategia salva-vita e costo-efficace? Primo trattato di Medicina Wilson and Jungner s criteria In the 1960s the World Health Organization adopted the Wilson and Jungner

More information

6/19/2018. Background Athlete s heart. Ultimate question. Applying the International Criteria for ECG

6/19/2018. Background Athlete s heart. Ultimate question. Applying the International Criteria for ECG Applying the International Criteria for ECG Interpretation in Athletes to a preparticipation screening program DAVE SIEBERT, MD, CAQSM ASSISTANT PROFESSOR DEPARTMENT OF FAMILY MEDICINE UNIVERSITY OF WASHINGTON

More information

Cardiac MRI: Clinical Application to Disease

Cardiac MRI: Clinical Application to Disease Cardiac MRI: Clinical Application to Disease Jessi Smith, MD Cardiothoracic imaging, Indiana University Slides courtesy of Stacy Rissing, MD Outline Imaging planes Disease findings Pulse sequences used

More information

What s New in Cardiac MRI

What s New in Cardiac MRI What s New in Cardiac MRI Katie M. Hawthorne, MD Director, Cardiac MRI Main Line Health Philadelphia Cardiovascular Summit November 18, 2017 Cardiac MRI: Disclosure 2 Disclosures No financial disclosures

More information

Tachycardias II. Štěpán Havránek

Tachycardias II. Štěpán Havránek Tachycardias II Štěpán Havránek Summary 1) Supraventricular (supraventricular rhythms) Atrial fibrillation and flutter Atrial ectopic tachycardia / extrabeats AV nodal reentrant a AV reentrant tachycardia

More information

Investigating the family after a sudden cardiac death. Dr Catherine Mercer Consultant Clinical Geneticist, Wessex

Investigating the family after a sudden cardiac death. Dr Catherine Mercer Consultant Clinical Geneticist, Wessex Investigating the family after a sudden cardiac death Dr Catherine Mercer Consultant Clinical Geneticist, Wessex Sudden adult deaths subdivided Sudden Adult Death Sudden Cardiac Death Sudden Arrhythmic

More information

Jonathan Kim MD, FACC

Jonathan Kim MD, FACC Jonathan Kim MD, FACC Assistant Professor, Division of Cardiology, Emory University Adjunct Assistant Professor, School of Applied Physiology, Georgia Tech Team Cardiologist, Sports Medicine, Emory University

More information

EVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES

EVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES EVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES UNIT OF INHERITED CV DISEASES HEART CENTER OF THE YOUNG AND ATHLETES A DPT OF CARDIOLOGY UNIVERSITY OF ATHENS EVALUATION OF ELECTROCARDIOGRAPHIC

More information

Advances in Ablation Therapy for Ventricular Tachycardia

Advances in Ablation Therapy for Ventricular Tachycardia Advances in Ablation Therapy for Ventricular Tachycardia Nitish Badhwar, MD, FACC, FHRS Director, Cardiac Electrophysiology Training Program University of California, San Francisco For those of you who

More information

What s new in Hypertrophic Cardiomyopathy?

What s new in Hypertrophic Cardiomyopathy? What s new in Hypertrophic Cardiomyopathy? Dr Andris Ellims HCM Clinic @ The Alfred Hypertrophic Cardiomyopathy = otherwise unexplained LV hypertrophy* 1 in 500 prevalence most common inherited cardiovascular

More information

An Approach to the Patient with Syncope. Guy Amit MD, MPH Soroka University Medical Center Beer-Sheva

An Approach to the Patient with Syncope. Guy Amit MD, MPH Soroka University Medical Center Beer-Sheva An Approach to the Patient with Syncope Guy Amit MD, MPH Soroka University Medical Center Beer-Sheva Case presentation A 23 y.o. man presented with 2 episodes of syncope One during exercise,one at rest

More information

Cardiac MRI: Cardiomyopathy

Cardiac MRI: Cardiomyopathy Cardiac MRI: Cardiomyopathy Laura E. Heyneman, MD I do not have any relevant financial relationships with any commercial interests Cardiac MRI: Cardiomyopathy Laura E. Heyneman, MD Duke University Medical

More information

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia By Sandeep Joshi, MD and Jonathan S. Steinberg, MD Arrhythmia Service, Division of Cardiology

More information

Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Analysis based on six cases

Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Analysis based on six cases ORIGINAL ARTICLE Cardiology Journal 2007, Vol. 14, No. 4, pp. 396 401 Copyright 2007 Via Medica ISSN 1897 5593 Arrhythmogenic right ventricular cardiomyopathy/dysplasia: Analysis based on six cases Radosław

More information

EKG screening in athletics

EKG screening in athletics Use of PPE EKG screening in athletics Stefan Montgomery MD, ATC 4/27/18 The overall role of the preparticipation physical evaluation (PPE) is to evaluate the health of the athlete to optimize safe sports

More information

Right ventricular adaptation in endurance athletes. António Freitas. No conflict of interest

Right ventricular adaptation in endurance athletes. António Freitas. No conflict of interest The role of echocardiography in sports cardiology Right ventricular adaptation in endurance athletes. António Freitas Cardiology Department - Fernando Fonseca Hospital Lisbon Sports Medicine Centre - Lisbon

More information

Left-Dominant Arrhythmogenic Cardiomyopathy

Left-Dominant Arrhythmogenic Cardiomyopathy Journal of the American College of Cardiology Vol. 52, No. 25, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.09.019

More information

Isolated Cardiac Sarcoidosis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy

Isolated Cardiac Sarcoidosis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy doi: 10.2169/internalmedicine.9395-17 Intern Med Advance Publication http://internmed.jp CASE REPORT Isolated Cardiac Sarcoidosis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy Hirotaka Waki

More information

Update in Cardiomyopathies: Their New Classifications and Importance of Mixed Phenotypes

Update in Cardiomyopathies: Their New Classifications and Importance of Mixed Phenotypes Update in Cardiomyopathies: Their New Classifications and Importance of Mixed Phenotypes Andre Keren MD Hadassah-Hebrew University Hospital, Jerusalem Cesarea, 2008 f o s r a es e y t hi 0 a 5 p t o rs

More information

Cardiac MRI: Clinical Application to Disease

Cardiac MRI: Clinical Application to Disease Cardiac MRI: Clinical Application to Disease Stacy Rissing, MD! Cardiothoracic imaging, Indiana University! Outline Imaging planes Disease findings Pulse sequences used for each indication Pathophysiology

More information

Impact of the Revision of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Task Force Criteria on Its Prevalence by CMR Criteria

Impact of the Revision of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Task Force Criteria on Its Prevalence by CMR Criteria JACC: CARDIOVASCULAR IMAGING VOL. 4, NO. 3, 2011 2011 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/$36.00 PUBLISHED BY ELSEVIER INC. DOI:10.1016/j.jcmg.2011.01.005 Impact of the Revision

More information

Paroxysmal Supraventricular Tachycardia PSVT.

Paroxysmal Supraventricular Tachycardia PSVT. Atrial Tachycardia; is the name for an arrhythmia caused by a disorder of the impulse generation in the atrium or the AV node. An area in the atrium sends out rapid signals, which are faster than those

More information

THE ROLE OF MOLECULAR AUTOPSY IN 2014: FROM THE ANATOMICAL THEATRE TO THE DOUBLE HELIX. Gaetano Thiene, MD

THE ROLE OF MOLECULAR AUTOPSY IN 2014: FROM THE ANATOMICAL THEATRE TO THE DOUBLE HELIX. Gaetano Thiene, MD THE ROLE OF MOLECULAR AUTOPSY IN 2014: FROM THE ANATOMICAL THEATRE TO THE DOUBLE HELIX Gaetano Thiene, MD Torino, October 23, 2014 The Role of the Autopsy in SD To establish or consider: whether the death

More information

The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.s358l mutation in TMEM43

The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.s358l mutation in TMEM43 Clin Genet 2013: 83: 321 331 Printed in Singapore. All rights reserved Original Article 2012 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd CLINICAL GENETICS doi: 10.1111/j.1399-0004.2012.01919.x

More information

Apical Hypertrophic Cardiomyopathy With Hemodynamically Unstable Ventricular Arrhythmia Atypical Presentation

Apical Hypertrophic Cardiomyopathy With Hemodynamically Unstable Ventricular Arrhythmia Atypical Presentation Cronicon OPEN ACCESS Hemant Chaturvedi* Department of Cardiology, Non-Invasive Cardiology, Eternal Heart Care Center & research Institute, Rajasthan, India Received: September 15, 2015; Published: October

More information

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD Imaging in Heart Failure: A Multimodality Approach Thomas Ryan, MD Heart Failure HFrEF HFpEF EF50% Lifetime risk 20% Prevalence 6M Americans Societal costs - $30B 50% 5-year survival 1 Systolic

More information

Arrhythmogenic right ventricular cardiomyopathy/dysplasia

Arrhythmogenic right ventricular cardiomyopathy/dysplasia ORIGINAL ARTICLE Cardiology Journal 2010, Vol. 17, No. 2, pp. 172 178 Copyright 2010 Via Medica ISSN 1897 5593 Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Iraq Amar Al-Hamdi 1, 2, Tahseen

More information

How NOT to miss Hypertrophic Cardiomyopathy? Adaya Weissler-Snir, MD University Health Network, University of Toronto

How NOT to miss Hypertrophic Cardiomyopathy? Adaya Weissler-Snir, MD University Health Network, University of Toronto How NOT to miss Hypertrophic Cardiomyopathy? Adaya Weissler-Snir, MD University Health Network, University of Toronto Introduction Hypertrophic cardiomyopathy is the most common genetic cardiomyopathy,

More information

Mitral Valve Disease, When to Intervene

Mitral Valve Disease, When to Intervene Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages

More information

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and 1 The clinical syndrome of heart failure in adults is commonly associated with the etiologies of ischemic and non-ischemic dilated cardiomyopathy, hypertrophic cardiomyopathy, hypertensive heart disease,

More information

Πρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια:

Πρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια: Πρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια: Νεώτερα δεδομένα στη διαστρωμάτωση κινδύνου Εμμ. Μ. Κανουπάκης MD, PhD, FESC Πανεπιστημιακό Νοσοκομείο Ηρακλείου NIDCM Presence of LV dilatation

More information

Sudden Death (SD) and hypertrophic cardiomyopathy (HCM) Attempt of risk stratification

Sudden Death (SD) and hypertrophic cardiomyopathy (HCM) Attempt of risk stratification Sudden Death (SD) and hypertrophic cardiomyopathy (HCM) Attempt of risk stratification 84th Annual Scientific Meeting of the Aerospace Medical Association May 12-16, 2013 Sheraton Chicago Hotel & Towers,

More information

Non-Cardiac Sudden Death in a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy

Non-Cardiac Sudden Death in a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy HOSPITAL CHRONICLES 2012, 7(3): 182 187 Case Report Non-Cardiac Sudden Death in a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy Skevos Sideris, MD, Emmanouil Poulidakis, MD, Konstantinos

More information

Interpretation and Consequences of Repolarisation Changes in Athletes

Interpretation and Consequences of Repolarisation Changes in Athletes Interpretation and Consequences of Repolarisation Changes in Athletes Professor Sanjay Sharma E-mail sasharma@sgul.ac.uk @SSharmacardio Disclosures: None Athlete s ECG Vagotonia Sinus bradycardia Sinus

More information

Cardiomyopathy in Fabry s disease

Cardiomyopathy in Fabry s disease Cardiomyopathy in Fabry s disease Herzinsuffizienzlunch Basel, 11.09.2018 Christiane Gruner Kardiologie, UniversitätsSpital Zürich Content Background / epidemiology Differential diagnosis Clinical presentations

More information

Current Indications for Cardiac MRI: What You See is What You Get?

Current Indications for Cardiac MRI: What You See is What You Get? Current Indications for Cardiac MRI: What You See is What You Get? Javier Ganame, MD, PhD, FASE No disclosures Cardiology Update, Niagara, Sept 24th, 2016 The Ideal Diagnostic Technique Easy to apply Accurate

More information

Cardiomyopathy. ACOI IM Board Review 2018 Martin C. Burke DO, FACOI

Cardiomyopathy. ACOI IM Board Review 2018 Martin C. Burke DO, FACOI Cardiomyopathy ACOI IM Board Review 2018 Martin C. Burke DO, FACOI No Disclosures Cardiomyopathies Definition: diseases of heart muscle 1980 WHO: unknown causes Not clinically relevant 1995 WHO: diseases

More information

SEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers !

SEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers ! Sudden cardiac death in the adult Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel.! " # $ % Cancers National Vital Statistics Report, Vol 49 (11), Oct. 12, 2001. 20% 25% State-specific

More information

Antony French Consultant Cardiologist & Electrophysiologist

Antony French Consultant Cardiologist & Electrophysiologist Antony French Consultant Cardiologist & Electrophysiologist Palpitations Unpleasant awareness of rapid or forceful heart beat Not all tachycardias cause palpitations, and not all palpitations are due to

More information

HYPERTROPHY: Behind the curtain. V. Yotova St. Radboud Medical University Center, Nijmegen

HYPERTROPHY: Behind the curtain. V. Yotova St. Radboud Medical University Center, Nijmegen HYPERTROPHY: Behind the curtain V. Yotova St. Radboud Medical University Center, Nijmegen Disclosure of interest: none Relative wall thickness (cm) M 0.22 0.42 0.43 0.47 0.48 0.52 0.53 F 0.24 0.42 0.43

More information

SABIHA GATI AND SANJAY SHARMA

SABIHA GATI AND SANJAY SHARMA 9 The athlete s heart SABIHA GATI AND SANJAY SHARMA Pasieka/Science Photo Library In this article, the authors highlight the spectrum, magnitude and determinants of the athlete s heart and provide a practical

More information

The Heart Is A Muscle Too! The Cardiomyopathy In Duchenne Muscular Dystrophy

The Heart Is A Muscle Too! The Cardiomyopathy In Duchenne Muscular Dystrophy The Heart Is A Muscle Too! The Cardiomyopathy In Duchenne Muscular Dystrophy Linda Cripe MD Professor of Pediatrics Nationwide Children s Hospital/The Ohio State University.... Why are cardiologists

More information

CARDIOMYOPATHY IN CT. Hans- Christoph Becker Professor of Radiology

CARDIOMYOPATHY IN CT. Hans- Christoph Becker Professor of Radiology CARDIOMYOPATHY IN CT Hans- Christoph Becker Professor of Radiology 1 Cardiomyopathy Heart muscle disease Deterioration of the heart function, heart failure Dyspnea, peripheral edema Risk of arrhythmia,

More information

Study methodology for screening candidates to athletes risk

Study methodology for screening candidates to athletes risk 1. Periodical Evaluations: each 2 years. Study methodology for screening candidates to athletes risk 2. Personal history: Personal history of murmur in childhood; dizziness, syncope, palpitations, intolerance

More information

Newly Diagnosed Heart Failure patient: When to Order an MRI and Why

Newly Diagnosed Heart Failure patient: When to Order an MRI and Why Newly Diagnosed Heart Failure patient: When to Order an MRI and Why Jennifer Dickerson MD Assistant Professor of Clinical Internal Medicine Director, The Ohio State University Echocardiography Laboratory

More information

Arrhythmias on the AMU

Arrhythmias on the AMU Arrhythmias on the AMU Dr Andrew R. Houghton United Lincolnshire Hospitals NHS Trust @arh_cardio An arrhythmia is present in 10% of admissions to the AMU Case history AMU referral to cardiology 25 yr 2-3

More information

NEW GUIDELINES MAJOR ECHOCARDIOGRAPHIC CRITERIA FOR ARVC MINOR ECHOCARDIOGRAPHIC CRITERIA FOR ARVC

NEW GUIDELINES MAJOR ECHOCARDIOGRAPHIC CRITERIA FOR ARVC MINOR ECHOCARDIOGRAPHIC CRITERIA FOR ARVC NEW GUIDELINES The Echocardiographic Assessment of the Right Ventricle with particular reference to Arrhythmogenic Right Ventricular Cardiomyopathy A Protocol of the British Society of Echocardiography

More information

3/17/2014. WS # 3 ICD Registry Case Scenarios with Structural Abnormalities. Objectives. Denise Pond BSN, RN

3/17/2014. WS # 3 ICD Registry Case Scenarios with Structural Abnormalities. Objectives. Denise Pond BSN, RN WS # 3 ICD Registry Case Scenarios with Structural Abnormalities Denise Pond BSN, RN The following relationships exist related to this presentation: No Disclosures Objectives Discuss specific coding instructions

More information

Clinical Genetics in Cardiomyopathies

Clinical Genetics in Cardiomyopathies Clinical Genetics in Cardiomyopathies Γεώργιος Κ Ευθυμιάδης Αναπληρωτής Καθηγητής Καρδιολογίας ΑΠΘ No conflict of interest Genetic terms Proband: The first individual diagnosed in a family Mutation: A

More information

SUDDEN CARDIAC DEATH(SCD): Definition

SUDDEN CARDIAC DEATH(SCD): Definition SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY

More information

Role of CMR in heart failure and cardiomyopathy

Role of CMR in heart failure and cardiomyopathy Role of CMR in heart failure and cardiomyopathy Hajime Sakuma Department of Radiology, Mie University Late gadolinium enhancement (LGE) LGE MRI can demonstrate site of necrosis, fibrosis or deposition

More information

La strategia diagnostica: il monitoraggio ecg prolungato. Michele Brignole

La strategia diagnostica: il monitoraggio ecg prolungato. Michele Brignole La strategia diagnostica: il monitoraggio ecg prolungato Michele Brignole ECG monitoring and syncope In-hospital monitoring Holter Monitoring External loop recorder Remote (at home) telemetry Implantable

More information

VENTRICULAR TACHYCARDIA IN THE ABSENCE OF STRUCTURAL HEART DISEASE

VENTRICULAR TACHYCARDIA IN THE ABSENCE OF STRUCTURAL HEART DISEASE VENTRICULAR TACHYCARDIA IN THE ABSENCE OF STRUCTURAL HEART DISEASE Dimosthenis Avramidis, MD. Consultant Mitera Children s Hospital Athens Greece Scientific Associate 1st Cardiology Dpt Evangelismos Hospital

More information